A combination of neuroimaging, CSF evidence of central nervous system inflammation, histological confirmation of systemic sarcoidosis, or indirect markers such as FDG-PET, gallium scan, or elevated serum angiotensin-converting enzyme (ACE) supports a diagnosis of neurosarcoidosis [6]. Here, ACE is linked to neurosarcoidosis.